TTUHSC School of Pharmacy

Office of Outcomes Assessment


The Office of Outcomes Assessment is committed to assessment and evaluation of school of pharmacy curriculum. Its mission is to develop consistently reliable assessment and analysis which will enhance educational outcomes of administration, faculties and students.


Dr. Shah
Sachin Shah, Pharm.D., BCOP, FCCP
Associate Dean, Assessment & Accreditation
Professor, Pharmacy Practice - Dallas
Office Phone: 214-358-9042
Mail Address: 4500 S Lancaster Rd Bldg 7 R#119A
Dallas, TX 75216-7167
Dr. Sachin Shah is an Associate Professor and Associate Dean at Texas Tech. He practices as a Hematology/Oncology Clinical Pharmacist. He received his Doctor of Pharmacy degree from the Texas Tech University HSC – School of Pharmacy and completed his general and oncology pharmacy residencies in San Antonio, Texas. He joined Texas Tech in 2002 and developed clinical oncology pharmacy program at the Dallas VA Medical Center. In addition, Dr. Shah established ASHP accredited Hematology/Oncology Specialty Residency program and trained multiple students and residents through his practice. Dr. Shah has been recipient of Lewis S. Smith Pharmacy Practitioner Award and Lou Cuellar Circle of Excellence leadership awards at the TSHP. In addition, he has received HOPA Clinical Practice Award. Dr. Shah has delivered multiple national presentations and served as a faculty on BCOP Preparatory Review Course.

Iverlyn Peng
Iverlyn Peng
Office Phone: 214-358-9035
Mail Address: 4500 S Lancaster Rd Bldg 7 R#119A
Dallas, TX 75216-7167
Iverlyn Peng was born in Taiwan and graduated from the University of Texas at Arlington in 2006. She started working for the Texas Tech University Health Sciences Center School of Pharmacy in 2014. Prior to her time with the SOP, Iverlyn worked in student and business support services. She lives in Arlington with her husband and two dogs. She enjoys traveling, gardening, music and exploring Texas for the best BBQ.


Annually the Office of Outcomes Assessment and the Student Assessment of Learning (SAL) Committee administer and evaluate HRDKA and PCOA assessments. The Committee is responsible of developing policy and making recommendations as required in all matters relating to assessing student progress in achieving the educational outcomes.

The SAL Committee Members

Committee Faculty Members

Brian Irons, Chair, Lubbock

Daniel (Cole) Kildow, Chair Elect, Dallas

Nishil Desai, Abilene

Vardan Karamyan, Amarillo

Nikita Mirajkar, Amarillo

Crystal Rendon-Brown, Dallas

Janie Robles, Lubbock

Sachin Shah, Associate Dean, Outcomes Assessment, Executive Committee Liaison (Ex Officio), Dallas

Elected Students

Patrick McGowen, P2, Amarillo

Justin Miranda, P4, Lubbock

Sarah Turner, P3, Dallas

High Risk Drug Knowledge Assessment (HRDKA): The HRDKA is a key evaluation of basic student knowledge of drugs prior to their entry into the Advanced Pharmacy Practice Experiences (APPE) of the P4 curriculum. The assessment evaluates student knowledge of top 200 drugs in the area of in- and out-patient pharmacies.

High Risk Drug Knowledge Assessment (HRDKA) Information Link

Pharmacy Curriculum Outcomes Assessment (PCOA): The PCOA is a key evaluation of student learning during each year of the curriculum. It provides students with individual performance measures. The exam is used as a gauge of the School of Pharmacy’s performance compared to other schools of pharmacy. This assessment is created by National Association of Boards of Pharmacy.

Pharmacy Curriculum Outcomes Assessment (PCOA) Information Link


SOP OP: 80.P.05 Procedures for Poor Performance on the Pharmacy Curriculum Outcomes Assessment (PCOA) Exam

SOP OP: 80.P.06 Policy for Poor Performance on the School’s P3 High Risk Drug Knowledge Assessment (HRDKA)


PCOA - National Association of Boards of Pharmacy Website

Pharmacy Times - Top 200 Drugs of 2012

For information and questions about Outcomes Assessment, please e-mail

back to top